Gestalt, a leader in digital pathology solutions, and Paige, the leader in next-generation AI technology for pathology, are excited to announce a strategic partnership to integrate Paige's advanced AI applications within Gestalt's award-winning PathFlow solution. This collaboration aims to streamline the delivery of integrated workflows, optimizing the pathologist's experience...
Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, announced a partnership with neuroscience solutions leader Cogstate to reshape clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders, among others.
Together, the...
Quris-AI (Quris), a leading Bio-AI company focused on revolutionizing the pharmaceutical drug development process, announced the successful asset acquisition of Nortis, recently known as Numa Biosciences, Inc., and will be opening access to publicly funded data within its expansive microphysiology systems (MPS) database.
Quris-AI will integrate Nortis's pioneering Kidney-on-Chip technology,...
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, fuel growth within the United States (US), and develop leading foundation...
Tempus, a leader in artificial intelligence and precision medicine, announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical companies in Korea, to leverage both real-world data (RWD) and biological modeling to support efficient hypothesis generation and rapid validation in early therapeutic research in oncology. JW Pharma...
Tevogen Bio, a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announces its Artificial Intelligence effort, Tevogen AI, has joined Microsoft for Startups. This partnership marks a significant milestone for Tevogen, providing unparalleled access to Microsoft’s extensive ecosystem. The partnership is...
Bioptimus, a French startup building the reference AI foundation model in biology, is excited to announce that its best-in-class H-optimus-0 foundation model is now integrated into Proscia’s Concentriq® Embeddings, enabling data scientists and researchers in pathology and life sciences to achieve breakthroughs in AI development at unprecedented speed and scale....
Sapio Sciences, the science-aware™ lab informatics platform, announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform. These new capabilities in the Sapio LIMS (Laboratory Information Management System) and Sapio ELN (Electronic Lab Notebook) solutions streamline testing workflows for detecting anti-drug antibodies (ADA) and neutralizing antibodies (NAb).
Immunogenicity bioanalysis follows...
Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a fundamental step forward in designing more effective drugs to treat age-related diseases. Today the company announced that it has raised $16M (£12.5M) in...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits that will enable automation to ensure greater consistency and increased efficiency of large-scale, single-cell discovery studies.
The automated solution from the BD and Hamilton...
